Urteste S.A. (URT.WA)
PLN 92.8
(-1.28%)
PLN 92.8
(-1.28%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 312 Thousand PLN | -34.04% |
| 2022 | 473 Thousand PLN | 0.0% |
| 2021 | - PLN | 0.0% |
| 2020 | - PLN | 0.0% |
| 2019 | - PLN | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 333 Thousand PLN | 0.0% |
| 2024 Q2 | 296 Thousand PLN | 0.0% |
| 2023 Q1 | 441 Thousand PLN | -6.77% |
| 2023 Q4 | 312 Thousand PLN | -44.48% |
| 2023 Q3 | 562 Thousand PLN | 9.98% |
| 2023 Q2 | 511 Thousand PLN | 15.87% |
| 2023 FY | 312 Thousand PLN | -34.04% |
| 2022 Q1 | - PLN | 0.0% |
| 2022 Q4 | 473 Thousand PLN | -6.34% |
| 2022 Q3 | 505 Thousand PLN | -5.78% |
| 2022 Q2 | 536 Thousand PLN | 0.0% |
| 2022 FY | 473 Thousand PLN | 0.0% |
| 2021 Q1 | - PLN | 0.0% |
| 2021 FY | - PLN | 0.0% |
| 2021 Q4 | - PLN | 0.0% |
| 2021 Q3 | - PLN | 0.0% |
| 2021 Q2 | - PLN | 0.0% |
| 2020 FY | - PLN | 0.0% |
| 2019 FY | - PLN | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bioceltix S.A. | 76.33 Thousand PLN | -308.735% |
| BIOTON S.A. | 12.67 Million PLN | 97.539% |
| Captor Therapeutics Spolka Akcyjna | 1.24 Million PLN | 74.98% |
| Mabion S.A. | 2.94 Million PLN | 89.417% |
| Molecure S.A. | 4.97 Million PLN | 93.73% |
| NanoGroup S.A. | - PLN | -Infinity% |
| Pharmena S.A. | 114 Thousand PLN | -173.684% |
| Poltreg S.A. | 7.8 Million PLN | 96.001% |
| Pure Biologics Spólka Akcyjna | 12.85 Million PLN | 97.572% |
| Ryvu Therapeutics S.A. | 365 Thousand PLN | 14.521% |
| Synthaverse S.A. | 61.2 Million PLN | 99.49% |